
Nicotine dependence is common among drug and alcohol dependent patients. This multi-site trial evaluated the effectiveness of smoking-cessation treatment with transdermal nicotine patch replacement (SC) as an adjunct to treatment-as-usual for illicit substance abuse (TAU). Cigarette smokers from five methadone-maintenance clinics and two drug and alcohol dependence treatment programs were randomly assigned to receive either SC as an adjunct to usual care or TAU. SC consisted of 1 week of group counseling before the target quit date and 8 weeks of group counseling plus transdermal nicotine patch replacement treatment after the target quit date.
Reid, M., et al. (2008). Smoking cessation treatment in community-based substance abuse rehabilitation programs. Journal of Substance Abuse Treatment 35(1):68-77.
http://www.ncbi.nlm.nih.gov/pubmed/17951021
Principal Investigator(s):
John Rotrosen, M.D.
Professor
NYU School of Medicine
Department of Psychiatry
One Park Avenue, 8th Floor
New York, NY 10016
john.rotrosen@nyumc.org
Participating Sites
- Mount Sinai Medical Center, New York
- Narco Freedom, Inc., New York
- St. Luke's Roosevelt Hospital Center
- Daymark Recovery Services, Inc., New York
- Matrix Institute on Addictions, California
- Tarzana Treatment Center, California
- Behavioral Health Services of Pickens County, South Carolina
- Coastal Horizons Center, Inc., North Carolina